Incidence rates of the most common canine tumors based on data from the Swiss Canine Cancer Registry (2008 to 2020).
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2024
2024
Historique:
received:
06
10
2023
accepted:
29
03
2024
medline:
18
4
2024
pubmed:
18
4
2024
entrez:
18
4
2024
Statut:
epublish
Résumé
Monitoring neoplasms in standardized registries facilitates epidemiologic studies of risk factors for tumor development and predisposition. In an observational study, we determined incidence rates (IR) and malignant tumor incidence rate ratios (IRR) by age, sex, and breed in Swiss dogs using demographic data from the official Swiss dog registration database Amicus. The dataset analyzed included 54'986 tumors diagnosed by histology and cytology in four Swiss veterinary pathology laboratories between 2008 and 2020. Diagnoses were coded according to the Vet-ICD-O-canine-1 system. Most tumors occurred in the skin (n = 19'045; 34.64%), soft tissues (n = 11'092; 20.17%), and mammary glands (n = 7'974; 14.50%). The IRs for all and for malignant tumors were 775/100'000 dog-years at risk (95%CI 764-777) and 338/100'000 dog-years at risk (95%CI 333-342), respectively. Females (850; 95%CI 834-853) had a higher overall tumor IR than males (679; 95%CI 666-684). The highest tumor IR was found at 11 years of age (1'857; 95%CI 1'780-1'867). Potential novel breed-specific predispositions were uncovered, with high IRs for several benign and malignant tumors in Polski Owczarek Nizinnys (overall IR: 3'303; 95%CI 2'502-3'864) and high IRs for malignant tumors in Russian Black Terriers (melanomas: 345; 95%CI 138-708), Field Spaniels (adenocarcinomas: 376; CI95% 138-817), Dogo Argentinos (mast cell tumors: 844; CI95% 591-1'169), King Charles Spaniels and Manchester Terriers (lymphomas: 319; CI95% 137-627 and 302; CI95% 98-704, respectively), Landseers (osteosarcomas: 74; CI95% 15-216), Bouvier des Flandres (hemangiosarcomas: 127; CI95% 26-371), and Bearded Collies and Cane Corso Italianos (gliomas: 91; CI95% 45-162 and 34; CI95% 7-99, respectively). Nordic hunting dogs had the highest (8.08; CI95% 3.55-16.7) and Chihuahueno the lowest cancer IRRs (0.42; 95%CI 0.31-0.57) compared to mixed breeds. In conclusion, the calculated IRs and IRRs revealed previously unknown predisposing factors, including novel breed-specific susceptibilities. The results may have implications for cancer screening, diagnostic work-up, breeding management and oncologic and translational research.
Identifiants
pubmed: 38635572
doi: 10.1371/journal.pone.0302231
pii: PONE-D-23-32527
pmc: PMC11025767
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0302231Informations de copyright
Copyright: © 2024 Dhein et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2015 May 18;10(5):e0127381
pubmed: 25992997
J Comp Pathol. 2016 Aug-Oct;155(2-3):156-170
pubmed: 27406312
J Natl Cancer Inst. 1968 Feb;40(2):295-305
pubmed: 5694271
Vet Comp Oncol. 2012 Jun;10(2):95-101
pubmed: 22236279
Conserv Genet. 2020 Feb;21(1):137-148
pubmed: 32607099
J Comp Pathol. 2015 Feb-Apr;152(2-3):161-71
pubmed: 25824119
J Am Vet Med Assoc. 2011 Oct 1;239(7):960-5
pubmed: 21961635
J Vet Intern Med. 2018 Nov;32(6):2054-2060
pubmed: 30307659
Can Vet J. 2022 Nov;63(11):1129-1134
pubmed: 36325409
Vet Sci. 2022 Sep 28;9(10):
pubmed: 36288148
J Vet Intern Med. 2006 May-Jun;20(3):669-75
pubmed: 16734106
PLoS Genet. 2021 Apr 1;17(4):e1009395
pubmed: 33793571
Vet Sci. 2022 Mar 31;9(4):
pubmed: 35448665
Vet Pathol. 2018 Nov;55(6):809-820
pubmed: 30131007
Vet Comp Oncol. 2010 Dec;8(4):283-92
pubmed: 21062410
Vet Rec. 2010 May 8;166(19):586-90
pubmed: 20453236
J Am Vet Med Assoc. 2004 Apr 15;224(8):1290-7
pubmed: 15112777
Urol Oncol. 2000 Mar-Apr;5(2):47-59
pubmed: 21227289
Canine Med Genet. 2021 Mar 10;8(1):2
pubmed: 33750475
Can J Vet Res. 2007 Oct;71(4):292-9
pubmed: 17955904
J Vet Intern Med. 2008 Jul-Aug;22(4):976-84
pubmed: 18564221
J Natl Cancer Inst. 1968 Feb;40(2):307-18
pubmed: 5694272
Nature. 2005 Dec 8;438(7069):803-19
pubmed: 16341006
Genomics. 2007 Sep;90(3):354-63
pubmed: 17628392
J Vet Intern Med. 2013 Sep-Oct;27(5):1143-52
pubmed: 23865437
PLoS One. 2018 Apr 13;13(4):e0195970
pubmed: 29652921
Canine Genet Epidemiol. 2018 Aug 13;5:5
pubmed: 30123514
Nat Rev Cancer. 2006 Aug;6(8):603-12
pubmed: 16862191
J Vet Med Sci. 2016 Sep 1;78(8):1269-75
pubmed: 27150207
Vet Rec. 2000 Sep 9;147(11):291-5
pubmed: 11037728
BMC Vet Res. 2017 Jun 28;13(1):203
pubmed: 28659149
Ann Ist Super Sanita. 2019 Oct-Dec;55(4):357-362
pubmed: 31850863
Prev Vet Med. 2005 Jun 10;69(1-2):109-27
pubmed: 15899300
Prev Vet Med. 2001 Sep 20;51(1-2):125-36
pubmed: 11530199
Canine Genet Epidemiol. 2015 Jan 26;2:1
pubmed: 26401329
Acta Vet Scand. 2005;46(3):105-20
pubmed: 16261924
Cancers (Basel). 2022 Mar 16;14(6):
pubmed: 35326681
APMIS Suppl. 2008;(125):5-18
pubmed: 19385278
ISRN Vet Sci. 2013 Jan 17;2013:941275
pubmed: 23738139
Vet Comp Oncol. 2022 Mar;20(1):246-255
pubmed: 34480391
J Am Vet Med Assoc. 2011 Apr 1;238(7):898-904
pubmed: 21453178
Vet J. 2013 Dec;198(3):678-83
pubmed: 24231621
Prev Vet Med. 2020 Aug;181:105074
pubmed: 32634752
J Small Anim Pract. 2010 Oct;51(10):512-24
pubmed: 21029096
Aging Cancer. 2022 Mar;3(1):3-19
pubmed: 35993010
BMC Vet Res. 2009 Jan 30;5:5
pubmed: 19183476
J Vet Intern Med. 2011 Mar-Apr;25(2):187-98
pubmed: 21352376
Vet Pathol. 1978 Nov;15(6):700-15
pubmed: 220774
BMC Vet Res. 2014 Jan 31;10:34
pubmed: 24484635
J Small Anim Pract. 2002 Jun;43(6):240-6
pubmed: 12074288
BMC Vet Res. 2016 Jul 25;12(1):153
pubmed: 27457701
Vet Q. 1994 Dec;16(4):209-19
pubmed: 7740746
J Comp Pathol. 2022 Oct;198:33-55
pubmed: 36116890
PLoS Biol. 2010 Aug 10;8(8):e1000451
pubmed: 20711490
Vet Comp Oncol. 2017 Jun;15(2):307-314
pubmed: 26300427
J Am Anim Hosp Assoc. 2011 May-Jun;47(3):210-6
pubmed: 21498594
Vet Sci. 2022 Dec 24;10(1):
pubmed: 36669010
Vet J. 1998 Jul;156(1):31-9
pubmed: 9691849
Vet Comp Oncol. 2022 Dec;20(4):797-804
pubmed: 35574975
J Vet Med Sci. 2019 Aug 24;81(8):1133-1143
pubmed: 31257236